Skip to content

Phase3,Randomized,Double-Blinded,Clinical Trial of NPC-01 for Treatment of Dysmenorrhea.

Phase3,Randomized,Double-Blinded,Clinical Trial of NPC-01 for Treatment of Dysmenorrhea.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221084
Enrollment
Unknown
Registered
2010-04-30
Start date
2010-04-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysmenorrhea

Interventions

investigational material(s) Generic name etc : NPC-01 INN of investigational material : Therapeutic category code : 247 Estrogen and gestagen preparations Dosage and Administration for Investigationa

Sponsors

Nobelpharma Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: dysmenorrhea

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
dysmenorrhea score(verbal rating scale)

Secondary

MeasureTime frame
dysmenorrhea score(visual analogue scale)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026